Medicine
fromNews Center
6 days agoInvestigating New Treatments for Spinal Muscular Atrophy - News Center
Apitegromab showed encouraging safety and efficacy for improving motor function in nonambulatory children and adolescents with type 2 or 3 spinal muscular atrophy.